Xanthus Pharmaceuticals
Online search and redirects.
Launch date
Market cap
-
Enterprise valuation
$100—150m (Dealroom.co estimates Dec 2006.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$20.4m | Series A | ||
$30.8m | Series B | ||
$25.0m | Series B | ||
| N/A | £25.0m | Acquisition | |
| Total Funding | $76.2m | ||